The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Virus-like particles in vaccine development
Abstract
Virus-like particles (VLPs) are multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccine candidates. A handful of prophylactic VLP-based vaccines is currently commercialized worldwide: GlaxoSmithKline's Engerix (hepatitis B virus) and Cervarix (human papillomavirus), and Merck and Co., Inc.'s Recombivax HB (hepatitis B virus) and Gardasil (human papillomavirus) are some examples. Other VLP-based vaccine candidates are in clinical trials or undergoing preclinical evaluation, such as, influenza virus, parvovirus, Norwalk and various chimeric VLPs. Many others are still restricted to small-scale fundamental research, despite their success in preclinical tests. This article focuses on the essential role of VLP technology in new-generation vaccines against prevalent and emergent diseases. The implications of large-scale VLP production are discussed in the context of process control, monitorization and optimization. The main up- and down-stream technical challenges are identified and discussed accordingly. Successful VLP-based vaccine blockbusters are briefly presented concomitantly with the latest results from clinical trials and the recent developments in chimeric VLP-based technology for either therapeutic or prophylactic vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
D'Souza, G., Kreimer, A. R., Viscidi, R., Pawlita, M., Fakhry, C., Koch, W. M., Westra, W. H., & Gillison, M. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065497 · Cited by 2,692
Chapter 2: The burden of HPV-related cancers
Parkin, D. M., & Bray, F. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.111 · Cited by 1,385
Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., & Schiller, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12180 · Cited by 1,110
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast
Valenzuela, P., Medina, A., Rutter, W. J., Ammerer, G., & Hall, B. D. (1982) · Nature · doi:10.1038/298347a0 · Cited by 877
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein
Jiang, X., Wang, M., Graham, D. Y., & Estes, M. K. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6527-6532.1992 · Cited by 860
Global control of hepatitis B virus infection
Kao, J.-H., & Chen, D.-S. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00315-8 · Cited by 805
A universal influenza A vaccine based on the extracellular domain of the M2 protein
Neirynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Jou, W. M., & Fiers, W. (1999) · Nature Medicine · doi:10.1038/13484 · Cited by 752
Suzich, J. A., Ghim, S. J., Palmer-Hill, F. J., White, W. I., Tamura, J. K., Bell, J. A., Newsome, J. A., Jenson, A. B., & Schlegel, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11553 · Cited by 668
Virus-like particles: Passport to immune recognition
Grgacic, E. V. L., & Anderson, D. A. (2006) · Methods · doi:10.1016/j.ymeth.2006.07.018 · Cited by 582
Virus-like particles as immunogens
Noad, R., & Roy, P. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00208-7 · Cited by 581
Cloned Viral Protein Vaccine for Foot-and-Mouth Disease: Responses in Cattle and Swine
Kleid, D. G., Yansura, D., Small, B., Dowbenko, D., Moore, D. M., Grubman, M. J., McKercher, P. D., Morgan, D. O., Robertson, B. H., & Bachrach, H. L. (1981) · Science · doi:10.1126/science.6272395 · Cited by 498
Structure of Small Virus-like Particles Assembled from the L1 Protein of Human Papillomavirus 16
Chen, X. S., Garcea, R. L., Goldberg, I., Casini, G., & Harrison, S. C. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80449-9 · Cited by 471
A plant‐derived edible vaccine against hepatitis B virus
Kapusta, J., Modelska, A., Figlerowicz, M., Pniewski, T., Letellier, M., Lisowa, O., Yusibov, V., Koprowski, H., Plucienniczak, A., & Legocki, A. B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1796 · Cited by 386
Baker, T. S., Newcomb, W. W., Olson, N. H., Cowsert, L. M., Olson, C., & Brown, J. C. (1991) · Biophysical Journal · doi:10.1016/s0006-3495(91)82181-6 · Cited by 385
Rose, R. C., Bonnez, W., Reichman, R. C., & Garcea, R. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1936-1944.1993 · Cited by 381
The coming of age of virus-like particle vaccines
Jennings, G. T., & Bachmann, M. F. (2008) · bchm · doi:10.1515/bc.2008.064 · Cited by 369
Cregg, J. M., Tschopp, J. F., Stillman, C., Siegel, R., Akong, M., Craig, W. S., Buckholz, R. G., Madden, K. R., Kellaris, P. A., Davis, G. R., et al. (1987) · Nature Biotechnology · doi:10.1038/nbt0587-479 · Cited by 334
Interior Surface Modification of Bacteriophage MS2
Hooker, J. M., Kovacs, E. W., & Francis, M. B. (2004) · Journal of the American Chemical Society · doi:10.1021/ja031790q · Cited by 334
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
Schiller, J. T., Castellsagué, X., Villa, L. L., & Hildesheim, A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.002 · Cited by 334
M2e-based universal influenza A vaccine
Fiers, W., De Filette, M., Bakkouri, K. E., Schepens, B., Roose, K., Schotsaert, M., Birkett, A., & Saelens, X. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.007 · Cited by 334
Quan, F.-S., Huang, C., Compans, R. W., & Kang, S.-M. (2007) · Journal of Virology · doi:10.1128/jvi.02052-06 · Cited by 313
Virus-like particles—universal molecular toolboxes
Ludwig, C., & Wagner, R. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.10.013 · Cited by 303
Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen
Valenzuela, P., Gray, P., Quiroga, M., Zaldivar, J., Goodman, H. M., & Rutter, W. J. (1979) · Nature · doi:10.1038/280815a0 · Cited by 300
Bright, R. A., Carter, D. M., Daniluk, S., Toapanta, F. R., Ahmad, A., Gavrilov, V., Massare, M., Pushko, P., Mytle, N., Rowe, T., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.106 · Cited by 288
Zlotnick, A., Cheng, N., Conway, J. F., Booy, F. P., Steven, A. C., Stahl, S. J., & Wingfield, P. T. (1996) · Biochemistry · doi:10.1021/bi9604800 · Cited by 287
Storni, T., Ruedl, C., Schwarz, K., Schwendener, R. A., Renner, W. A., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1777 · Cited by 286
Tissot, A. C., Maurer, P., Nussberger, J., Sabat, R., Pfister, T., Ignatenko, S., Volk, H.-D., Stocker, H., Müller, P., Jennings, G. T., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60381-5 · Cited by 286
A vaccine against nicotine for smoking cessation: a randomized controlled trial
Cornuz, J., Zwahlen, S., Jungi, W. F., Osterwalder, J., Klingler, K., van Melle, G., Bangala, Y., Guessous, I., Müller, P., Willers, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002547 · Cited by 281
Maurer, P., Jennings, G. T., Willers, J., Rohner, F., Lindman, Y., Roubicek, K., Renner, W. A., Müller, P., & Bachmann, M. F. (2005) · European Journal of Immunology · doi:10.1002/eji.200526285 · Cited by 279
D’Aoust, M., Lavoie, P., Couture, M. M. ‐., Trépanier, S., Guay, J., Dargis, M., Mongrand, S., Landry, N., Ward, B. J., & Vézina, L. (2008) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2008.00384.x · Cited by 279
HBV Core Particles as a Carrier for B Cell/T Cell Epitopes
Pumpens, P., & Grens, E. (2001) · Intervirology · doi:10.1159/000050037 · Cited by 274
Scaleup of Insect Cell Cultures: Protective Effects of Pluronic F-68
Murhammer, D. W., & Goochee, C. F. (1988) · Nature Biotechnology · doi:10.1038/nbt1288-1411 · Cited by 257
Chackerian, B., Lowy, D. R., & Schiller, J. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11849 · Cited by 251
Mortola, E., & Roy, P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.009 · Cited by 250
PUSHKO, P., TUMPEY, T., BU, F., KNELL, J., ROBINSON, R., & SMITH, G. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.098 · Cited by 249
Native display of complete foreign protein domains on the surface of hepatitis B virus capsids
Kratz, P. A., Böttcher, B., & Nassal, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1915 · Cited by 248
Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322
Burrell, C. J., Mackay, P., Greenaway, P. J., Hofschneider, P. H., & Murray, K. (1979) · Nature · doi:10.1038/279043a0 · Cited by 241
Bright, R. A., Carter, D. M., Crevar, C. J., Toapanta, F. R., Steckbeck, J. D., Cole, K. S., Kumar, N. M., Pushko, P., Smith, G., Tumpey, T. M., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001501 · Cited by 240
Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers
Tacket, C. O., Sztein, M. B., Losonsky, G. A., Wasserman, S. S., & Estes, M. K. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00120-7 · Cited by 238
JEGERLEHNER, A. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00266-9 · Cited by 226
Universal influenza A vaccine: Optimization of M2-based constructs
De Filette, M., Min Jou, W., Birkett, A., Lyons, K., Schultz, B., Tonkyro, A., Resch, S., & Fiers, W. (2005) · Virology · doi:10.1016/j.virol.2005.04.004 · Cited by 223
Ambühl, P. M., Tissot, A. C., Fulurija, A., Maurer, P., Nussberger, J., Sabat, R., Nief, V., Schellekens, C., Sladko, K., Roubicek, K., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32800ff5d6 · Cited by 219
Advances in on-line monitoring and control of mammalian cell cultures: Supporting the PAT initiative
Teixeira, A. P., Oliveira, R., Alves, P. M., & Carrondo, M. J. T. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.05.003 · Cited by 193
Self-citationDeterminants of Autoantibody Induction by Conjugated Papillomavirus Virus-Like Particles
Chackerian, B., Lenz, P., Lowy, D. R., & Schiller, J. T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6120 · Cited by 181
Escherichia coli‐based cell‐free synthesis of virus‐like particles
Bundy, B. C., Franciszkowicz, M. J., & Swartz, J. R. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21716 · Cited by 179
Pinto, L. A., Edwards, J., Castle, P. E., Harro, C. D., Lowy, D. R., Schiller, J. T., Wallace, D., Kopp, W., Adelsberger, J. W., Baseler, M. W., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/376505 · Cited by 177
FRAZER, I., QUINN, M., NICKLIN, J., TAN, J., PERRIN, L., NG, P., OCONNOR, V, WHITE, O., WENDT, N., & MARTIN, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.05.013 · Cited by 176
Downstream processing of viral vectors and vaccines
Morenweiser, R. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302624 · Cited by 176
Virus-Like Particle Vaccine Conferred Complete Protection Against a Lethal Influenza Virus Challenge
Galarza, J. M., Latham, T., & Cupo, A. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.365 · Cited by 176
French, T. J., Marshall, J. J., & Roy, P. (1990) · Journal of Virology · doi:10.1128/jvi.64.12.5695-5700.1990 · Cited by 175
Insect Baculoviruses Strongly Potentiate Adaptive Immune Responses by Inducing Type I IFN
Hervas-Stubbs, S., Rueda, P., Lopez, L., & Leclerc, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2361 · Cited by 175
Cloning in Escherichia coli and physical structure of hepatitis B virion DNA.
Charnay, P., Pourcel, C., Louise, A., Fritsch, A., & Tiollais, P. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2222 · Cited by 167
Laurent, S., Vautherot, J. F., Madelaine, M. F., Le Gall, G., & Rasschaert, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.10.6794-6798.1994 · Cited by 164
The expression of hybrid HIV:Ty virus-like particles in yeast
Adams, S. E., Dawson, K. M., Gull, K., Kingsman, S. M., & Kingsman, A. J. (1987) · Nature · doi:10.1038/329068a0 · Cited by 164
Hong, S., Hwang, D., Yoon, S., Ole Isacson, A., Ramezani, A., Hawley, R. G., & Kim, K. S. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300251 · Cited by 155
Vassileva, A., Chugh, D. A., Swaminathan, S., & Khanna, N. (2001) · Protein Expression and Purification · doi:10.1006/prep.2000.1335 · Cited by 154
Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization
Quan, F., Compans, R. W., Nguyen, H. H., & Kang, S. (2007) · Journal of Virology · doi:10.1128/jvi.01615-07 · Cited by 150
Deml, L., Speth, C., Dierich, M. P., Wolf, H. J., & Wagner, R. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.028 · Cited by 147
Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris
Hardy, E., Martı́nez, E., Diago, D., et al. (2000) · Journal of Biotechnology · doi:10.1016/s0168-1656(99)00201-1 · Cited by 146
Influenza vaccines based on virus-like particles
Kang, S., Song, J.-M., Quan, F., & Compans, R. W. (2009) · Virus Research · doi:10.1016/j.virusres.2009.04.005 · Cited by 142
Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment
Roos, A., Eriksson, F., Timmons, J. A., Gerhardt, J., Nyman, U., Gudmundsdotter, L., Bråve, A., Wahrén, B., & Pisa, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007226 · Cited by 140
Wang, B., Quan, F., Kang, S., Bozja, J., Skountzou, I., & Compans, R. W. (2008) · Journal of Virology · doi:10.1128/jvi.01076-08 · Cited by 138
Antibodies from Women Immunized with Gardasil ® Cross-Neutralize HPV 45 Pseudovirions
Smith, J. F., Brownlow, M., Brown, M. J., Kowalski, R., Esser, M. T., Ruiz, W., Barr, E., Brown, D. R., & Bryan, J. T. (2007) · Human Vaccines · doi:10.4161/hv.3.4.4058 · Cited by 137
Hepatitis B vaccines: Protective efficacy and therapeutic potential
Michel, M.-L., & Tiollais, P. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2010.01.006 · Cited by 136
Swenson, D. L., Warfield, K. L., Negley, D. L., Schmaljohn, A. L., Aman, M. J., & Bavari, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.070 · Cited by 133
Mahmood, K., Bright, R. A., Mytle, N., Carter, D. M., Crevar, C. J., Achenbach, J. E., Heaton, P. M., Tumpey, T. M., & Ross, T. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.084 · Cited by 133
Krammer, F., Schinko, T., Palmberger, D., Tauer, C., Messner, P., & Grabherr, R. M. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9268-3 · Cited by 131
Bernal, V., Carinhas, N., Yokomizo, A. Y., Carrondo, M. J. T., & Alves, P. M. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22364 · Cited by 131
Self-citationMasotti, A., Mossa, G., Cametti, C., Ortaggi, G., Bianco, A., Grosso, N. D., Malizia, D., & Esposito, C. (2008) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2008.09.017 · Cited by 130
Galarza, J. M., Latham, T. E., & Cupo, A. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.244 · Cited by 129
Zhao, Q., Chen, J., Lv, T.-F., He, C., Tang, G., Liang, W., Tabata, Y., & Gao, J. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.706 · Cited by 127
Murawski, M. R., McGinnes, L. W., Finberg, R. W., Kurt‐Jones, E. A., Massare, M. J., Smith, G., Heaton, P. M., Fraire, A. E., & Morrison, T. G. (2009) · Journal of Virology · doi:10.1128/jvi.01709-09 · Cited by 127
Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1
Montross, L. K., Watkins, S. C., Moreland, R. B., Mamon, H. J., Caspar, D. L. D., & Garcea, R. L. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4991-4998.1991 · Cited by 126
Shioda, T., & Shibuta, H. (1990) · Virology · doi:10.1016/0042-6822(90)90194-v · Cited by 124
The process development challenge for a new vaccine
Buckland, B. C. (2005) · Nature Medicine · doi:10.1038/nm1218 · Cited by 118
Virus-like particles as HIV-1 vaccines
Doan, L. X., Li, M., Chen, C., & Yao, Q. C. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.449 · Cited by 116
Downstream processing of triple layered rotavirus like particles
Peixoto, C., Sousa, M. F. Q., Silva, A. C., Carrondo, M. J. T., & Alves, P. M. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.08.002 · Cited by 114
Self-citationMorris, T. D., & Miller, L. K. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7397-7405.1992 · Cited by 113
Mammalian Expression of Virus-Like Particles for Advanced Mimicry of Authentic Influenza Virus
Wu, C.-Y., Yeh, Y.-C., Yang, Y., Chou, C., Liu, M., Wu, H.-S., Chan, J.-T., & Hsiao, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009784 · Cited by 112
Heparin binding induces conformational changes in Adeno-associated virus serotype 2
Levy, H. C., Bowman, V. D., Govindasamy, L., McKenna, R., Nash, K., Warrington, K., Chen, W., Muzyczka, N., Yan, X., Baker, T. S., et al. (2009) · Journal of Structural Biology · doi:10.1016/j.jsb.2008.12.002 · Cited by 110
Chackerian, B., Rangel, M., Hunter, Z. N., & Peabody, D. S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.059 · Cited by 110
Liu, C., Dalby, B., Chen, W., Kilzer, J. M., & Chiou, H. C. (2008) · Molecular Biotechnology · doi:10.1007/s12033-008-9051-x · Cited by 110
Induction of Long-Term Protective Immune Responses by Influenza H5N1 Virus-Like Particles
Kang, S., Yoo, D., Lipatov, A. S., Song, J.-M., Davis, C. T., Quan, F., Chen, L., Donis, R. O., & Compans, R. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004667 · Cited by 109
Oliveira, G. A., Wetzel, K., Calvo‐Calle, J. M., Nussenzweig, R. S., Schmidt, A., Birkett, A. J., Dubovsky, F., Tierney, E. L., Gleiter, C. H., Boehmer, G., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3587-3597.2005 · Cited by 106
Canady, M. A., Tihova, M., Hanzlik, T. N., Johnson, J. E., & Yeager, M. J. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3723 · Cited by 106
Haynes, J. R., Dokken, L., Wiley, J. A., Cawthon, A. G., Bigger, J. E., Harmsen, A. G., & Richardson, C. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.011 · Cited by 103
Emeny, R. T., Wheeler, C. M., Jansen, K. U., Hunt, W. C., Fu, T., Smith, J. F., MacMullen, S. A., Esser, M. T., & Paliard, X. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7832-7842.2002 · Cited by 101
Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice
Quan, F., Vunnava, A., Compans, R. W., & Kang, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009161 · Cited by 99
Characterization of Rous Sarcoma Virus Gag Particles Assembled In Vitro
Yu, F., Joshi, S. M., Ma, Y. M., Kingston, R. L., Simon, M. N., & Vogt, V. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.2753-2764.2001 · Cited by 99
Nardin, E. H., Oliveira, G. A., Calvo‐Calle, J. M., Wetzel, K., Maier, C., Birkett, A. J., Sarpotdar, P. P., Corado, M. L., Thornton, G. B., & Schmidt, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6519-6527.2004 · Cited by 99
Pushko, P., Tumpey, T. M., Hoeven, N. V., Belser, J. A., Robinson, R., Nathan, M., Smith, G., Wright, D. C., & Bright, R. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.059 · Cited by 99
Rueda, P., Fominaya, J. M., Langeveld, J., Bruschke, C., Vela, C., & Casal, J. I. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00259-0 · Cited by 98
Anion-exchange membrane chromatography for purification of rotavirus-like particles
Vicente, T., Sousa, M. F. Q., Peixoto, C., Mota, J. P. B., Alves, P. M., & Carrondo, M. J. T. (2007) · Journal of Membrane Science · doi:10.1016/j.memsci.2007.12.021 · Cited by 98
Self-citationHIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae
Sakuragi, S., Goto, T., Sano, K., & Morikawa, Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082281199 · Cited by 97
Ramqvist, T., Andreasson, K., & Dalianis, T. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.997 · Cited by 94
Expression, purification and characterization of enterovirus-71 virus-like particles
Chung, Y.-C., Huang, J., Lai, C., Sheng, H.-C., Shih, S.-R., Ho, M.-S., & Hu, Y.-C. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i6.921 · Cited by 93
Protection against lethal challenge by Ebola virus-like particles produced in insect cells
Sun, Y., Carrion, R., Ye, L., Wen, Z., Ro, Y., Brasky, K. M., Ticer, A. E., Schwegler, E. E., Patterson, J. L., Compans, R. W., et al. (2008) · Virology · doi:10.1016/j.virol.2008.09.020 · Cited by 92
Effects of Oxygen on Recombinant Protein Expression
Konz, J., King, J. W., & Cooney, C. L. (1998) · Biotechnology Progress · doi:10.1021/bp980021l · Cited by 91
Improving baculovirus production at high cell density through manipulation of energy metabolism
Carinhas, N., Bernal, V., Monteiro, F., Carrondo, M. J. T., Oliveira, R., & Alves, P. M. (2009) · Metabolic Engineering · doi:10.1016/j.ymben.2009.08.008 · Cited by 91
Self-citationYamshchikov, G. V., Ritter, G., Vey, M., & Compans, R. W. (1995) · Virology · doi:10.1006/viro.1995.9955 · Cited by 91
In situ 2D fluorometry and chemometric monitoring of mammalian cell cultures
Teixeira, A. P., Portugal, C. A. M., Carinhas, N., Dias, J. M. L., Crespo, J. P., Alves, P. M., Carrondo, M. J. T., & Oliveira, R. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22125 · Cited by 90
Self-citationActive immunization with IL‐1 displayed on virus‐like particles protects from autoimmune arthritis
Spohn, G., Keller, I., Beck, M., Grest, P., Jennings, G. T., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737989 · Cited by 89
Xia, M., Farkas, T., & Jiang, X. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20762 · Cited by 88
Differential protein expression following low temperature culture of suspension CHO-K1 cells
Kumar, N., Gammell, P., Meleady, P., Henry, M. A., & CLYNES, M. M. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-42 · Cited by 87
Haglund, K., Forman, J. P., Kräusslich, H., & Rose, J. K. (2000) · Virology · doi:10.1006/viro.1999.0120 · Cited by 86
Tan, M., Zhong, W., Song, D., Thornton, S. A., & Jiang, X. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20228 · Cited by 86
Filovirus‐Like Particles Produced in Insect Cells: Immunogenicity and Protection in Rodents
Warfield, K. L., Posten, N. A., Swenson, D. L., Olinger, G. G., Esposito, D., Gillette, W., Hopkins, R. F., Costantino, J. A., Panchal, R. G., Hartley, J. L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/520612 · Cited by 85
Purification of recombinant baculoviruses for gene therapy using membrane processes
Vicente, T., Peixoto, C., Carrondo, M. J. T., & Alves, P. M. (2009) · Gene Therapy · doi:10.1038/gt.2009.33 · Cited by 83
Self-citationMeghrous, J., Aucoin, M. G., Jacob, D., Chahal, P. S., Arcand, N., & Kamen, A. (2005) · Biotechnology Progress · doi:10.1021/bp049802e · Cited by 83
Peacey, M., Wilson, S., Baird, M. A., & Ward, V. K. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21518 · Cited by 82
Rutgers, T., Gordon, D. M., GATHOYE, A., Hollingdale, M. R., Hockmeyer, W. T., Rosenberg, M. J., & Wilde, M. D. (1988) · Nature Biotechnology · doi:10.1038/nbt0988-1065 · Cited by 81
Schädlich, L., Senger, T., Kirschning, C. J., Müller, M., & Gissmann, L. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.014 · Cited by 76
de la Rosa, G. P., Monroy, A., Mora‐García, M. D. L., Reynaga‐Peña, C. G., Hernández‐Montes, J., Weiss‐Steider, B., & Gómez-Lim, M. Á. (2009) · Virology Journal · doi:10.1186/1743-422x-6-2 · Cited by 72
Tetracycline-Inducible Packaging Cell Line for Production of Flavivirus Replicon Particles
Harvey, T. J., Liu, W. J., Wang, X. J., Linedale, R., Jacobs, M., Davidson, A. D., Le, T. T., Anraku, I., Suhrbier, A., Shi, P., et al. (2003) · Journal of Virology · doi:10.1128/jvi.78.1.531-538.2004 · Cited by 71
Maranga, L., Cunha, A. E., Clemente, J. J., Cruz, P. E., & Carrondo, M. J. T. (2003) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2003.09.012 · Cited by 69
Self-citationSzécsi, J., Boson, B., Johnsson, P., Dupeyrot-Lacas, P., Matrosovich, M. N., Klenk, H. D., Klatzmann, D., Volchkov, V. E., & Cosset, F. (2006) · Virology Journal · doi:10.1186/1743-422x-3-70 · Cited by 68
Towards purification of adenoviral vectors based on membrane technology
Peixoto, C., Ferreira, T. B., Sousa, M. F. Q., Carrondo, M. J. T., & Alves, P. M. (2008) · Biotechnology Progress · doi:10.1002/btpr.25 · Cited by 67
Self-citationMeasurement of malaria vaccine efficacy in phase III trials: Report of a WHO consultation
Moorthy, V., Reed, Z. H., & Smith, P. G. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.085 · Cited by 66
Takehara, K., Ireland, D. C., & Bishop, D. H. L. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-11-2763 · Cited by 62
Coroadinha, A. S., Schucht, R., Gama-Norton, L., Wirth, D., Häuser, H., & Carrondo, M. J. T. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.01.037 · Cited by 61
Self-citationBetenbaugh, M. J., Yu, M., Kuehl, K. A., White, J., Pennock, D. G., Spik, K. W., & Schmaljohn, C. S. (1995) · Virus Research · doi:10.1016/0168-1702(95)00053-s · Cited by 61
Wang, K.-C., Wu, J.-C., Chung, Y.-C., Ho, Y., Chang, M. D., & Hu, Y. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20385 · Cited by 61
Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles
Guo, L., Lu, X., Kang, S., Chen, C., Compans, R. W., & Yao, Q. C. (2003) · Virology · doi:10.1016/s0042-6822(03)00372-6 · Cited by 60
Virus-Like Particles as a Modular System for Novel Vaccines
Lechner, F., Jegerlehner, A., Tissot, A. C., Maurer, P., Sebbel, P., Renner, W. A., Jennings, G. T., & Bachmann, M. F. (2002) · Intervirology · doi:10.1159/000067912 · Cited by 59
Matassov, D., Cupo, A., & Galarza, J. M. (2007) · Viral Immunology · doi:10.1089/vim.2007.0027 · Cited by 58
Analysis of Ebola virus and VLP release using an immunocapture assay
Kallstrom, G., Warfield, K. L., Swenson, D. L., Mort, S., Panchal, R. G., Ruthel, G. T., Bavari, S., & Aman, M. J. (2005) · Journal of Virological Methods · doi:10.1016/j.jviromet.2005.02.015 · Cited by 53
Zamora, E. D., Handisurya, A., Shafti‐Keramat, S., Borchelt, D., Rudow, G. L., Conant, K. E., Cox, C., Troncoso, J. C., & Kirnbauer, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2662 · Cited by 51
Peters, B. S., CHEINGSONG-POPOV, R., Callow, D., Foxall, R. B., Patou, G., Hodgkin, K., & Weber, J. N. (1997) · Journal of Infection · doi:10.1016/s0163-4453(97)92814-0 · Cited by 47
Synthesis of rotavirus-like particles in insect cells: Comparative and quantitative analysis
Jiang, B., Barniak, V. L., Smith, R. P., Sharma, R., Corsaro, B. G., Hu, B. T., & MADORE, H. P. (1998) · Biotechnology and Bioengineering · Cited by 43
Mellado, M. C. M., Mena, J. A., Lopes, A., Ramı́rez, O. T., Carrondo, M. J. T., Palomares, L. A., & Alves, P. M. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22430 · Cited by 42
Self-citationMartinelle, K., Doverskog, M., Jacobsson, U., Chapman, B. E., Kuchel, P. W., & Häggström, L. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19981120)60:4<408::aid-bit2>3.0.co;2-q · Cited by 40
Pumpens, P., Ražanskas, R., Pushko, P., Renhof, R., Gusars, I., Skrastiņa, D., Ose, V., Borisova, G., Sominskaya, I., Petrovskis, I., et al. (2002) · Intervirology · doi:10.1159/000050084 · Cited by 39
Almanza-Reyes, H. E., Cubillos‐Zapata, C., Angulo, I., Mateos, F., Castón, J. R., van der Poel, W. H. M., Vinjé, J., Bárcena, J., & Mena, I. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01204-08 · Cited by 38
Krammer, F., Nakowitsch, S., Messner, P., Palmberger, D., Ferko, B., & Grabherr, R. M. (2009) · Biotechnology Journal · doi:10.1002/biot.200900267 · Cited by 37
Matsuo, E., Tani, H., Lim, C., Komoda, Y., Okamoto, T., Miyamoto, H., Moriishi, K., Yagi, S., Patel, A. H., Miyamura, T., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.001 · Cited by 35
Effect of ammonia production on intracellular pH: Consequent effect on adenovirus vector production
Ferreira, T. B., Carrondo, M. J. T., & Alves, P. M. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.01.010 · Cited by 35
Self-citationRodgers, R., Chang, D., Cai, X., & Consigli, R. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.3386-3390.1994 · Cited by 33
Transcriptional profiling of batch and fed-batch protein-free 293-HEK cultures
Lee, Y. Y., Wong, K. T. K., Nissom, P. M., Wong, D. C. F., & Yap, M. G. S. (2006) · Metabolic Engineering · doi:10.1016/j.ymben.2006.08.006 · Cited by 32
Taube, S., Kurth, A. A., & Schreier, E. (2005) · Archives of Virology · doi:10.1007/s00705-005-0517-x · Cited by 32
Challenges in creating a vaccine to prevent hepatitis E
Maloney, B. J., Takeda, N., Suzaki, Y., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.11.020 · Cited by 30
Therapeutic vaccines for nicotine dependence.
Maurer, P., & Bachmann, M. F. (2006) · PubMed · Cited by 29
Wagner, R., Deml, L., Notka, F., Wolf, H. J., Schirmbeck, R., Reimann, J., Teeuwsen, V. J. P., & Heeney, J. L. (1996) · Intervirology · doi:10.1159/000150480 · Cited by 28
Therapeutic vaccination for future management of HIV/AIDS
Lisziewicz, J. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00569-8 · Cited by 28
Aucoin, M. G., Jacob, D., Chahal, P. S., Meghrous, J., Bernier, A., & Kamen, A. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-457-5_14 · Cited by 26
Pajot-Augy, E., Bozon, V., Rémy, J., Couture, L., & Salesse, R. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00241.x · Cited by 26
Low pH‐Triggered Model Drug Molecule Release from Virus‐Like Particles
Ohtake, N., Niikura, K., Suzuki, T., Nagakawa, K., Mikuni, S., Matsuo, Y., Kinjo, M., Sawa, H., & Ijiro, K. (2010) · ChemBioChem · doi:10.1002/cbic.201000094 · Cited by 25
Krammer, F., Schinko, T., Messner, P., Palmberger, D., Ferko, B., & Grabherr, R. M. (2010) · Journal of Virological Methods · doi:10.1016/j.jviromet.2010.03.003 · Cited by 25
Ko, Y.-J., Choi, K.-S., Nah, J., Paton, D. J., Oem, J., Wilsden, G., Kang, S., Jo, N.-I., Lee, J.-H., Kim, J., et al. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.8.922-929.2005 · Cited by 25
Sodium dodecyl sulfate-capillary gel electrophoresis analysis of rotavirus-like particles
Mellado, M. C. M., Franco, C. D. M. F., Coelho, A. V., et al. (2008) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.03.035 · Cited by 24
Self-citationChandran, D., Shahana, P. V., Rani, G. S., Sugumar, P., Shankar, C. R., & Srinivasan, V. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.093 · Cited by 19
Mellado, M. C. M., Peixoto, C., Cruz, P. E., Carrondo, M. J. T., & Alves, P. M. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.09.002 · Cited by 16
Self-citationWinblad, B. G. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.295 · Cited by 13
Zheng, X.-Z., Li, H., Du, L., Wang, H., & Gu, Q. (2009) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2009.2802 · Cited by 10
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Zhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Robilotti, E., Deresinski, S., & Pinsky, B. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00075-14 · Cited by 589
Vaccine delivery using nanoparticles
Gregory, A. E., Titball, R., & Williamson, D. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00013 · Cited by 561
Nanoparticle Vaccines Against Infectious Diseases
Pati, R., Shevtsov, M., & Sonawane, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02224 · Cited by 514
Metadata
- Authors
- Roldão, A., Mellado, M. C. M., Castilho, L. R., Carrondo, M. J., & Alves, P. M.
- Venue
- Expert Review of Vaccines
- Publisher
- Informa UK Limited
- Published
- 2010-10
- Volume
- 9
- Issue
- 10
- Pages
- 1149-1176
- ISSN
- 1476-0584 (ISSN-L)
- 1744-8395
- OpenAlex
- W2149913957
- Cited by
- 845
- References
- 154
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.